nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.0355	0.0423	CcSEcCtD
Indapamide—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.0313	0.0372	CcSEcCtD
Indapamide—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.028	0.0333	CcSEcCtD
Indapamide—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0185	0.022	CcSEcCtD
Indapamide—KCNE1—TarBasePathway—IGF1—amyotrophic lateral sclerosis	0.0174	0.175	CbGpPWpGaD
Indapamide—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.0172	0.0205	CcSEcCtD
Indapamide—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0196	CcSEcCtD
Indapamide—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0164	CcSEcCtD
Indapamide—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0162	CcSEcCtD
Indapamide—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0162	CcSEcCtD
Indapamide—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0159	CcSEcCtD
Indapamide—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0158	CcSEcCtD
Indapamide—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0149	CcSEcCtD
Indapamide—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0146	CcSEcCtD
Indapamide—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.012	0.0143	CcSEcCtD
Indapamide—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0134	CcSEcCtD
Indapamide—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0127	CcSEcCtD
Indapamide—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0096	0.0114	CcSEcCtD
Indapamide—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.0096	0.0114	CcSEcCtD
Indapamide—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00954	0.0114	CcSEcCtD
Indapamide—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00935	0.0111	CcSEcCtD
Indapamide—Gout—Riluzole—amyotrophic lateral sclerosis	0.00929	0.0111	CcSEcCtD
Indapamide—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00911	0.0108	CcSEcCtD
Indapamide—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00828	0.00985	CcSEcCtD
Indapamide—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00814	0.00969	CcSEcCtD
Indapamide—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00814	0.00969	CcSEcCtD
Indapamide—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00784	0.00933	CcSEcCtD
Indapamide—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0076	0.00905	CcSEcCtD
Indapamide—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00738	0.00878	CcSEcCtD
Indapamide—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00724	0.00861	CcSEcCtD
Indapamide—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00717	0.00853	CcSEcCtD
Indapamide—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00704	0.00838	CcSEcCtD
Indapamide—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00679	0.00808	CcSEcCtD
Indapamide—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0067	0.00798	CcSEcCtD
Indapamide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0067	0.00798	CcSEcCtD
Indapamide—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00667	0.00794	CcSEcCtD
Indapamide—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00664	0.00791	CcSEcCtD
Indapamide—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00653	0.00777	CcSEcCtD
Indapamide—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00648	0.00771	CcSEcCtD
Indapamide—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00632	0.00752	CcSEcCtD
Indapamide—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0063	0.00749	CcSEcCtD
Indapamide—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00625	0.00743	CcSEcCtD
Indapamide—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00738	CcSEcCtD
Indapamide—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00723	CcSEcCtD
Indapamide—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00592	0.00705	CcSEcCtD
Indapamide—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00697	CcSEcCtD
Indapamide—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00581	0.00692	CcSEcCtD
Indapamide—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00575	0.00684	CcSEcCtD
Indapamide—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00573	0.00682	CcSEcCtD
Indapamide—KCNE1—nervous system—amyotrophic lateral sclerosis	0.00566	0.094	CbGeAlD
Indapamide—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00663	CcSEcCtD
Indapamide—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00555	0.00661	CcSEcCtD
Indapamide—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00544	0.00648	CcSEcCtD
Indapamide—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00544	0.00648	CcSEcCtD
Indapamide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00544	0.00648	CcSEcCtD
Indapamide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00635	CcSEcCtD
Indapamide—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00631	CcSEcCtD
Indapamide—KCNQ1—TarBasePathway—IGF1—amyotrophic lateral sclerosis	0.00524	0.0527	CbGpPWpGaD
Indapamide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00523	0.00623	CcSEcCtD
Indapamide—CA4—nerve—amyotrophic lateral sclerosis	0.0051	0.0848	CbGeAlD
Indapamide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00606	CcSEcCtD
Indapamide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00598	CcSEcCtD
Indapamide—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00596	CcSEcCtD
Indapamide—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00497	0.00591	CcSEcCtD
Indapamide—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00586	CcSEcCtD
Indapamide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00581	CcSEcCtD
Indapamide—Depression—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00576	CcSEcCtD
Indapamide—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00563	CcSEcCtD
Indapamide—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00563	CcSEcCtD
Indapamide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00561	CcSEcCtD
Indapamide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00554	CcSEcCtD
Indapamide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00546	CcSEcCtD
Indapamide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00542	CcSEcCtD
Indapamide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00453	0.00539	CcSEcCtD
Indapamide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00437	0.0052	CcSEcCtD
Indapamide—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00518	CcSEcCtD
Indapamide—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00433	0.00516	CcSEcCtD
Indapamide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00514	CcSEcCtD
Indapamide—KCNQ1—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.0043	0.0433	CbGpPWpGaD
Indapamide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0043	0.00512	CcSEcCtD
Indapamide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00511	CcSEcCtD
Indapamide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00508	CcSEcCtD
Indapamide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00412	0.0049	CcSEcCtD
Indapamide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00481	CcSEcCtD
Indapamide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00463	CcSEcCtD
Indapamide—CA4—hindbrain—amyotrophic lateral sclerosis	0.00382	0.0635	CbGeAlD
Indapamide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00451	CcSEcCtD
Indapamide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00445	CcSEcCtD
Indapamide—Tension—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00443	CcSEcCtD
Indapamide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00442	CcSEcCtD
Indapamide—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00438	CcSEcCtD
Indapamide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00436	CcSEcCtD
Indapamide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00434	CcSEcCtD
Indapamide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00419	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00352	0.0354	CbGpPWpGaD
Indapamide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00417	CcSEcCtD
Indapamide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00415	CcSEcCtD
Indapamide—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00412	CcSEcCtD
Indapamide—KCNQ1—medulla oblongata—amyotrophic lateral sclerosis	0.00346	0.0575	CbGeAlD
Indapamide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00407	CcSEcCtD
Indapamide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00405	CcSEcCtD
Indapamide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00405	CcSEcCtD
Indapamide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00404	CcSEcCtD
Indapamide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00399	CcSEcCtD
Indapamide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00397	CcSEcCtD
Indapamide—Cough—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00394	CcSEcCtD
Indapamide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00384	CcSEcCtD
Indapamide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00384	CcSEcCtD
Indapamide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00384	CcSEcCtD
Indapamide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00383	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00382	CcSEcCtD
Indapamide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0038	CcSEcCtD
Indapamide—CA2—hindbrain—amyotrophic lateral sclerosis	0.00317	0.0527	CbGeAlD
Indapamide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00376	CcSEcCtD
Indapamide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00368	CcSEcCtD
Indapamide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00368	CcSEcCtD
Indapamide—Infection—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00366	CcSEcCtD
Indapamide—Shock—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00362	CcSEcCtD
Indapamide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00361	CcSEcCtD
Indapamide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00361	CcSEcCtD
Indapamide—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00359	CcSEcCtD
Indapamide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00358	CcSEcCtD
Indapamide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00356	CcSEcCtD
Indapamide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00351	CcSEcCtD
Indapamide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00344	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00336	CcSEcCtD
Indapamide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00333	CcSEcCtD
Indapamide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00331	CcSEcCtD
Indapamide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00328	CcSEcCtD
Indapamide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00327	CcSEcCtD
Indapamide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00324	CcSEcCtD
Indapamide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00269	0.0032	CcSEcCtD
Indapamide—CA7—cerebellum—amyotrophic lateral sclerosis	0.00268	0.0446	CbGeAlD
Indapamide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00318	CcSEcCtD
Indapamide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00318	CcSEcCtD
Indapamide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00315	CcSEcCtD
Indapamide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00315	CcSEcCtD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00263	0.0264	CbGpPWpGaD
Indapamide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00303	CcSEcCtD
Indapamide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00301	CcSEcCtD
Indapamide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00293	CcSEcCtD
Indapamide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00291	CcSEcCtD
Indapamide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00291	CcSEcCtD
Indapamide—CA9—cerebellum—amyotrophic lateral sclerosis	0.00236	0.0392	CbGeAlD
Indapamide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00271	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00227	0.0228	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00227	0.0228	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00227	0.0228	CbGpPWpGaD
Indapamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—amyotrophic lateral sclerosis	0.00225	0.0226	CbGpPWpGaD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00223	0.0225	CbGpPWpGaD
Indapamide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00264	CcSEcCtD
Indapamide—CA4—brainstem—amyotrophic lateral sclerosis	0.00219	0.0364	CbGeAlD
Indapamide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00261	CcSEcCtD
Indapamide—CA7—brain—amyotrophic lateral sclerosis	0.00218	0.0362	CbGeAlD
Indapamide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00252	CcSEcCtD
Indapamide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00244	CcSEcCtD
Indapamide—KCNQ1—brain—amyotrophic lateral sclerosis	0.00199	0.033	CbGeAlD
Indapamide—CA2—embryo—amyotrophic lateral sclerosis	0.00198	0.0329	CbGeAlD
Indapamide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00234	CcSEcCtD
Indapamide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00232	CcSEcCtD
Indapamide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00232	CcSEcCtD
Indapamide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00231	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00188	0.0189	CbGpPWpGaD
Indapamide—CA12—nervous system—amyotrophic lateral sclerosis	0.00185	0.0308	CbGeAlD
Indapamide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00219	CcSEcCtD
Indapamide—CA2—brainstem—amyotrophic lateral sclerosis	0.00182	0.0302	CbGeAlD
Indapamide—CA12—central nervous system—amyotrophic lateral sclerosis	0.00178	0.0296	CbGeAlD
Indapamide—KCNQ1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00173	0.0174	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00167	0.0168	CbGpPWpGaD
Indapamide—CA5B—nervous system—amyotrophic lateral sclerosis	0.00166	0.0276	CbGeAlD
Indapamide—CA5B—central nervous system—amyotrophic lateral sclerosis	0.0016	0.0266	CbGeAlD
Indapamide—KCNQ1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00153	0.0154	CbGpPWpGaD
Indapamide—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.00153	0.0254	CbGeAlD
Indapamide—KCNQ1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00142	0.0143	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00142	0.0143	CbGpPWpGaD
Indapamide—CA12—brain—amyotrophic lateral sclerosis	0.00142	0.0235	CbGeAlD
Indapamide—CA4—spinal cord—amyotrophic lateral sclerosis	0.00136	0.0226	CbGeAlD
Indapamide—CA5B—brain—amyotrophic lateral sclerosis	0.00127	0.0211	CbGeAlD
Indapamide—KCNQ1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00127	0.0128	CbGpPWpGaD
Indapamide—CA2—medulla oblongata—amyotrophic lateral sclerosis	0.00127	0.021	CbGeAlD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00117	0.0118	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00117	0.0118	CbGpPWpGaD
Indapamide—CA4—nervous system—amyotrophic lateral sclerosis	0.00115	0.0191	CbGeAlD
Indapamide—CA2—spinal cord—amyotrophic lateral sclerosis	0.00113	0.0188	CbGeAlD
Indapamide—CA4—central nervous system—amyotrophic lateral sclerosis	0.0011	0.0184	CbGeAlD
Indapamide—CA4—cerebellum—amyotrophic lateral sclerosis	0.00108	0.0179	CbGeAlD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000998	0.01	CbGpPWpGaD
Indapamide—CA9—Cellular response to hypoxia—VEGFA—amyotrophic lateral sclerosis	0.000993	0.00999	CbGpPWpGaD
Indapamide—CA2—nervous system—amyotrophic lateral sclerosis	0.000951	0.0158	CbGeAlD
Indapamide—SLC12A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000925	0.00931	CbGpPWpGaD
Indapamide—CA2—central nervous system—amyotrophic lateral sclerosis	0.000916	0.0152	CbGeAlD
Indapamide—CA2—cerebellum—amyotrophic lateral sclerosis	0.000895	0.0149	CbGeAlD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000889	0.00894	CbGpPWpGaD
Indapamide—CA4—brain—amyotrophic lateral sclerosis	0.000877	0.0146	CbGeAlD
Indapamide—CA9—Cellular responses to stress—GSR—amyotrophic lateral sclerosis	0.000837	0.00842	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VCP—amyotrophic lateral sclerosis	0.000808	0.00813	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000754	0.00758	CbGpPWpGaD
Indapamide—CA2—brain—amyotrophic lateral sclerosis	0.000727	0.0121	CbGeAlD
Indapamide—CA5A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000715	0.00719	CbGpPWpGaD
Indapamide—CA5A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000715	0.00719	CbGpPWpGaD
Indapamide—CA5B—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000668	0.00672	CbGpPWpGaD
Indapamide—CA7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000668	0.00672	CbGpPWpGaD
Indapamide—CA5B—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000668	0.00672	CbGpPWpGaD
Indapamide—CA7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000668	0.00672	CbGpPWpGaD
Indapamide—CA5A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000654	0.00658	CbGpPWpGaD
Indapamide—CA12—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000619	0.00622	CbGpPWpGaD
Indapamide—CA12—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000619	0.00622	CbGpPWpGaD
Indapamide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000614	0.0102	CbGeAlD
Indapamide—CA5B—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000611	0.00614	CbGpPWpGaD
Indapamide—CA7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000611	0.00614	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000608	0.00612	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000596	0.006	CbGpPWpGaD
Indapamide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000591	0.00982	CbGeAlD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000586	0.00589	CbGpPWpGaD
Indapamide—CA5A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000572	0.00575	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000568	0.00571	CbGpPWpGaD
Indapamide—CA7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000568	0.00571	CbGpPWpGaD
Indapamide—CA12—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000566	0.00569	CbGpPWpGaD
Indapamide—CA5B—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000534	0.00537	CbGpPWpGaD
Indapamide—CA7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000534	0.00537	CbGpPWpGaD
Indapamide—CA12—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000526	0.00529	CbGpPWpGaD
Indapamide—CA5A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000517	0.0052	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000507	0.0051	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000507	0.0051	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000497	0.005	CbGpPWpGaD
Indapamide—CA12—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000495	0.00497	CbGpPWpGaD
Indapamide—CA4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000493	0.00496	CbGpPWpGaD
Indapamide—CA4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000493	0.00496	CbGpPWpGaD
Indapamide—CA5B—Metabolism—DAO—amyotrophic lateral sclerosis	0.000483	0.00486	CbGpPWpGaD
Indapamide—CA7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000483	0.00486	CbGpPWpGaD
Indapamide—CA2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000473	0.00476	CbGpPWpGaD
Indapamide—CA2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000473	0.00476	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000457	0.00459	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000452	0.00454	CbGpPWpGaD
Indapamide—CA4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000451	0.00454	CbGpPWpGaD
Indapamide—CA12—Metabolism—DAO—amyotrophic lateral sclerosis	0.000447	0.0045	CbGpPWpGaD
Indapamide—CA2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000433	0.00435	CbGpPWpGaD
Indapamide—CA4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00042	0.00422	CbGpPWpGaD
Indapamide—CA2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000402	0.00404	CbGpPWpGaD
Indapamide—CA9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000399	0.00401	CbGpPWpGaD
Indapamide—CA9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000399	0.00401	CbGpPWpGaD
Indapamide—CA4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000394	0.00397	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000392	0.00394	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.000378	0.00381	CbGpPWpGaD
Indapamide—CA2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000378	0.0038	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.000369	0.00371	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000366	0.00368	CbGpPWpGaD
Indapamide—CA7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000366	0.00368	CbGpPWpGaD
Indapamide—CA9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000365	0.00367	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000362	0.00364	CbGpPWpGaD
Indapamide—CA4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000357	0.00359	CbGpPWpGaD
Indapamide—CA2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000342	0.00344	CbGpPWpGaD
Indapamide—CA9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000339	0.00341	CbGpPWpGaD
Indapamide—CA12—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000339	0.00341	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000338	0.0034	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSR—amyotrophic lateral sclerosis	0.000338	0.0034	CbGpPWpGaD
Indapamide—CA9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000319	0.00321	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSR—amyotrophic lateral sclerosis	0.000313	0.00315	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000297	0.00299	CbGpPWpGaD
Indapamide—CA9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000288	0.0029	CbGpPWpGaD
Indapamide—CA7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000277	0.00279	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000277	0.00279	CbGpPWpGaD
Indapamide—CA4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00027	0.00272	CbGpPWpGaD
Indapamide—CA2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000259	0.00261	CbGpPWpGaD
Indapamide—CA12—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000257	0.00258	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSR—amyotrophic lateral sclerosis	0.00025	0.00251	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000239	0.00241	CbGpPWpGaD
Indapamide—CA9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000218	0.0022	CbGpPWpGaD
Indapamide—CA4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000205	0.00206	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000202	0.00203	CbGpPWpGaD
Indapamide—CA2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000196	0.00198	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000196	0.00197	CbGpPWpGaD
Indapamide—CA9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000166	0.00166	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00016	0.00161	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	0.000151	0.00152	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000149	0.0015	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000149	0.0015	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000147	0.00148	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000138	0.00139	CbGpPWpGaD
Indapamide—CA7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000137	0.00138	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000137	0.00138	CbGpPWpGaD
Indapamide—CA12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000127	0.00128	CbGpPWpGaD
Indapamide—CA5A—Metabolism—APOE—amyotrophic lateral sclerosis	0.000121	0.00121	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	0.000114	0.00115	CbGpPWpGaD
Indapamide—CA7—Metabolism—APOE—amyotrophic lateral sclerosis	0.000113	0.00113	CbGpPWpGaD
Indapamide—CA5B—Metabolism—APOE—amyotrophic lateral sclerosis	0.000113	0.00113	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00011	0.00111	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000106	0.00106	CbGpPWpGaD
Indapamide—CA12—Metabolism—APOE—amyotrophic lateral sclerosis	0.000104	0.00105	CbGpPWpGaD
Indapamide—CA4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000101	0.00102	CbGpPWpGaD
Indapamide—CA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.7e-05	0.000976	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.9e-05	0.000895	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.76e-05	0.000881	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.64e-05	0.000869	CbGpPWpGaD
Indapamide—CA4—Metabolism—APOE—amyotrophic lateral sclerosis	8.33e-05	0.000837	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.27e-05	0.000832	CbGpPWpGaD
Indapamide—CA9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.18e-05	0.000822	CbGpPWpGaD
Indapamide—CA2—Metabolism—APOE—amyotrophic lateral sclerosis	7.98e-05	0.000803	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.72e-05	0.000777	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.72e-05	0.000777	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.15e-05	0.000719	CbGpPWpGaD
Indapamide—CA9—Metabolism—APOE—amyotrophic lateral sclerosis	6.73e-05	0.000677	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	6.71e-05	0.000675	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	6.71e-05	0.000675	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.14e-05	0.000617	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.71e-05	0.000574	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.7e-05	0.000574	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.47e-05	0.00055	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.37e-05	0.00054	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.85e-05	0.000488	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.61e-05	0.000464	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.68e-05	0.00037	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.39e-05	0.000341	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.79e-05	0.00028	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.5e-05	0.000151	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000138	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.13e-05	0.000114	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.76e-06	7.8e-05	CbGpPWpGaD
